Artificial intelligence-driven drug development against autoimmune diseases
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference89 articles.
1. Human autoimmune diseases: a comprehensive update;Wang;J. Intern. Med.,2015
2. Complexity and heterogeneity, the defining features of autoimmune disease;Sanz;Curr. Opin. Immunol.,2019
3. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases;Fugger;Cell,2020
4. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology;Schrezenmeier;Nat. Rev. Rheumatol.,2020
5. Exploring the role of immunotherapeutic drugs in autoimmune diseases: a comprehensive review;Patil;J. Oral Biol. Craniofac. Res.,2021
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects;European Journal of Medicinal Chemistry;2024-10
2. The mechanism of action and chemical synthesis of FDA newly approved drug molecules;Drug Development Research;2024-09
3. Revolutionary Point‐of‐Care Wearable Diagnostics for Early Disease Detection and Biomarker Discovery through Intelligent Technologies;Advanced Science;2024-07-03
4. Harnessing the power of AI-based models to accelerate drug discovery against immune diseases;Expert Review of Clinical Immunology;2024-07
5. Machine learning techniques for prediction in pregnancy complicated by autoimmune rheumatic diseases: Applications and challenges;International Immunopharmacology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3